EDMA Consolidated Market Statistics are among the best tools available for understanding the trends in our industry. They are a valuable asset for the IVD industry, and EDMA thanks all companies and countries participating in the European Diagnostic Market Statistics (EDMS) programme.

The accuracy of data is high and major countries have more than 85% of the market covered by companies reporting invoiced sales to an independent auditor. Although IVDs provide critical health information and are crucial for patient outcome, their cost as a percentage of the total healthcare expenditure is low (less than 2%). Short-term investments in IVDs will result in long-term benefits for healthcare.

EDMA 2008 Market Estimates

 

Two EDMA programmes allow companies to have access to timely market intelligence data:

• The European Diagnostic Market Statistics (EDMS) is essential for marketing departments, providing detailed market reports quarterly in eleven countries.

• The Management Information System (MIS) is essential for company management, providing monthly top line market reports and covering all European countries plus Turkey.

  

The product classification scheme allows for the compiling and consolidation of market estimate data. You can find more information about Products Classification here.

 

For more information about Market Estimates, EDMS, MIS or the EDMA Classification, please contact Miriam Gargesi, Public Affairs and Communications Manager.